Pancreatic Cancer Diagnosis: Family Fights for Private Treatment for Craig Sullivan
Stage four pancreatic cancer diagnosis at age 45 following initial irritable bowel syndrome attribution prompts a Nottinghamshire family to seek £50,000 in private funding for treatments unavailable on the National Health Service. Craig Sullivan received his diagnosis a year after his initial stomach pain began, a delay that led his wife Natalie to state, “I wish we’d pushed for more help sooner.”
- Craig Sullivan was diagnosed with stage four pancreatic cancer at age 45 following an initial attribution of his symptoms to irritable bowel syndrome.
- Only about 3% of all money invested into cancer research in the UK goes towards studying pancreatic cancer, according to Pancreatic Cancer UK figures.
- Family and friends are aiming to raise £50,000 for alternative private treatments in Oxford or Germany that are unavailable on the NHS for his specific type of cancer.
Stomach Pain Misattributed to Irritable Bowel Syndrome Before Scan Discovers Pancreas Mass
When Craig Sullivan initially experienced stomach pain, he attributed the discomfort to a stressful house move and a heavy workload. Medical professionals initially attributed his symptoms to irritable bowel syndrome due to his age of 44. His condition subsequently deteriorated, leading to diagnostic tests and scans that confirmed stage four pancreatic cancer one year later.
The turning point occurred when Craig woke up with yellow skin and eyes, prompting Natalie to take him to A&E at Queen’s Medical Centre in Nottingham. Initial medical assessments suggested blockages or gallstones, but subsequent imaging revealed a mass on his pancreas. Now 45, Craig underwent six rounds of chemotherapy to reduce the tumour size for potential surgical removal. Although the tumour shrunk by half by April, treating physicians remained uncomfortable proceeding with an operation and recommended additional chemotherapy. An intervening infection caused treatment cancellation, and follow-up scans demonstrated that the cancer had metastasized to his liver.

Only 1.1% of Pancreatic Cancer Diagnoses Occur in Patients Under 45
Pancreatic cancer predominantly affects individuals over the age of 65, those with chronic pancreatitis, and people carrying a family history of the disease, according to the NHS. Common clinical indicators include yellowing of the skin or whites of the eyes, itchy skin, darker urine, pale stools, unexplained weight loss, fatigue, appetite loss, and fluctuating body temperatures. Data from Pancreatic Cancer UK indicates that an average of 136 individuals under 45 are diagnosed annually in the UK, accounting for 1.1% of total cases.
Charlotte Lynch, senior policy advisor for Pancreatic Cancer UK, noted that the disease is exceptionally difficult to diagnose early because symptoms remain vague. Lynch added that available standard treatments carry severe side effects, frequently leaving patients too unwell to receive them. The charity continues to lobby the government for increased research investment, pointing out that approximately 3% of all UK cancer research funding is directed toward pancreatic cancer.
Palliative Care Pathway Reached After Spread to the Liver
Following the detection of liver tumours, Craig completed 10 rounds of chemotherapy before transitioning to a palliative care pathway. Restricted by current National Institute of Clinical Excellence (NICE) guidelines, the family cannot access specific private-tier treatments on the NHS for his exact cancer classification.
Meanwhile, community fundraising efforts led by organisers like Laura Burton aim to raise £50,000 for alternative treatments in Oxford or Germany. While these therapies cannot cure the disease, the family hopes they will extend Craig’s time with his sons Alfie, 14, and Quinn, 10.
Patients experiencing persistent, unexplained digestive symptoms or jaundice should seek prompt evaluation from qualified gastroenterologists or general practitioners to ensure timely diagnostic imaging.